Zobrazeno 1 - 10
of 175
pro vyhledávání: '"Sergio Storti"'
Autor:
Livio Pagano, Marianna Criscuolo, Alessandro Broccoli, Alfonso Piciocchi, Marzia Varettoni, Eugenio Galli, Antonella Anastasia, Maria Cantonetti, Livio Trentin, Sofia Kovalchuk, Lorella Orsucci, Annamaria Frustaci, Angelica Spolzino, Stefano Volpetti, Ombretta Annibali, Sergio Storti, Caterina Stelitano, Francesco Marchesi, Massimo Offidani, Beatrice Casadei, Maria Elena Nizzoli, Maria Lucia De Luca, Luana Fianchi, Marina Motta, Luca Guarnera, Edoardo Simonetti, Andrea Visentin, Francesco Vassallo, Marina Deodato, Chiara Sarlo, Attilio Olivieri, Brunangelo Falini, Alessandro Pulsoni, Enrico Tiacci, Pier Luigi Zinzani
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 7, Pp 1-8 (2022)
Abstract Hairy cell leukemia (HCL) is a rare lymphoproliferative disease with an excellent prognosis after treatment with cladribine (2CDA), although relapse may occur during follow-up. The aim of the study is to review the efficacy, safety, long-ter
Externí odkaz:
https://doaj.org/article/b587414ecc684a018ac33515eebf5f44
Autor:
Sergio Storti, Michele Spina, Emanuela Anna Pesce, Flavia Salvi, Michele Merli, Alessia Ruffini, Giuseppina Cabras, Annalisa Chiappella, Emanuele Angelucci, Alberto Fabbri, Anna Marina Liberati, Monica Tani, Gerardo Musuraca, Annalia Molinari, Maria Pia Petrilli, Carmela Palladino, Rosanna Ciancia, Andrea Ferrario, Cristiana Gasbarrino, Federico Monaco, Vincenzo Fraticelli, Annalisa De Vellis, Francesco Merli, Stefano Luminari
Publikováno v:
Haematologica, Vol 103, Iss 8 (2018)
We conducted a phase II study to assess activity and safety profile of bendamustine and rituximab in elderly patients with untreated diffuse large B-cell lymphoma (DLBCL) who were prospectively defined as frail using a simplified version of the Compr
Externí odkaz:
https://doaj.org/article/113d9dc70ef24344a9ccaa66f023382d
Autor:
Alessandro Broccoli, Cinzia Pellegrini, Alice Di Rocco, Benedetta Puccini, Caterina Patti, Guido Gini, Donato Mannina, Monica Tani, Chiara Rusconi, Alessandra Romano, Anna Vanazzi, Barbara Botto, Carmelo Carlo-Stella, Stefan Hohaus, Pellegrino Musto, Patrizio Mazza, Stefano Molica, Paolo Corradini, Angelo Fama, Francesco Gaudio, Michele Merli, Angela Gravetti, Giuseppe Gritti, Annalisa Arcari, Patrizia Tosi, Anna Marina Liberati, Antonello Pinto, Vincenzo Pavone, Filippo Gherlinzoni, Virginia Naso, Stefano Volpetti, Livio Trentin, Maria Cecilia Goldaniga, Maurizio Bonfichi, Amalia De Renzo, Corrado Schiavotto, Michele Spina, Sergio Storti, Angelo Michele Carella, Vittorio Stefoni, Lisa Argnani, Pier Luigi Zinzani
Publikováno v:
Haematologica, Vol 102, Iss 11 (2017)
Between November 2012 and July 2014, in accordance with national law 648/96, brentuximab vedotin was available in Italy for patients with relapsed systemic anaplastic large cell lymphoma outside a clinical trial context. A large Italian observational
Externí odkaz:
https://doaj.org/article/a663cbb1e87b4e5a949b59a8ab0a0e7f
Autor:
Maurizio Pompili, Maria Basso, Stefan Hohaus, Giulia Bosco, Lorenzo Nosotti, Mariella D’Andrea, Susanna Fenu, Antonio Grieco, Luca Laurenti, Concetta Mirisola, Livio Pagano, Gian Ludovico Rapaccini, Simona Sica, Sergio Storti, Raffaele Landolfi
Publikováno v:
Annals of Hepatology, Vol 14, Iss 2, Pp 168-174 (2015)
Background and aim. The best strategy for managing patients with resolved hepatitis B virus infection (HBsAg negative, anti-HBc antibodies positive with or without anti-HBs antibodies) and hematological malignancies under immunosuppressive therapies
Externí odkaz:
https://doaj.org/article/b464324bcd0e4103a8ad7f918bf3a01b
Autor:
Paola Tacchetti, Lucia Pantani, Francesca Patriarca, Maria Teresa Petrucci, Elena Zamagni, Luca Dozza, Monica Galli, Francesco Di Raimondo, Claudia Crippa, Mario Boccadoro, Simona Barbato, Patrizia Tosi, Franco Narni, Vittorio Montefusco, Nicoletta Testoni, Antonio Spadano, Carolina Terragna, Norbert Pescosta, Giulia Marzocchi, Claudia Cellini, Piero Galieni, Sonia Ronconi, Marco Gobbi, Lucio Catalano, Antonio Lazzaro, Giovanni De Sabbata, Clotilde Cangialosi, Fabrizio Ciambelli, Pellegrino Musto, Francesca Elice, Michele Cavo, Renato Fanin, Roberto Foa', Alessandro Rambaldi, Giuseppe Rossi, Pietro Leoni, Paolo Corradini, Giuseppe Torelli, Giuseppe Fioritoni, Sergio Cortelazzo, Giorgio Lambertenghi Deliliers, Giorgio La Nasa, Alfonso Zaccaria, Paolo De Fabritiis, Nicola Cascavilla, Alberto Bosi, Gianpietro Semenzato, Luigi Gugliotta, Filippo Gherlinzoni, Emanuele Angelucci, Massimo Fabrizio Martelli, Maria Concetta Petti, Giuseppe Leone, Angelo Michele Carella, Fabio Ciceri, Armando Santoro, Felicetto Ferrara, Francesco Nobile, Alfonso Maria D'Arco, Alessandro Levis, Luciano Guardigni, Andrea Gallamini, Pier Paolo Fattori, Sergio Morandi, Dino Amadori, Bruno Rotoli, Salvatore Mirto, Giorgio Paladini, Ruggero Mozzana, Graziella Pinotti, Francesco Rodeghiero, Nicola Cantore, Vincenzo Pavone, Enrico Maria Pogliani, Anna Marina Liberati, Ignazio Majolino, Sergio Amadori, Francesco Lauria, Massimo Aglietta, Giovanni Quarta, Sergio Storti, Fortunato Morabito, Silvana Franca Capalbo, Alessandro Massimo Gianni, Vincenzo Mettivier, Vittorio Rizzoli, Carlo Bernasconi, Giuseppe Visani, Michele Pizzuti, Giacinto La Verde, Giuseppe Avvisati, Maurizio Longinotti, Eugenio Gallo, Franco Dammacco, Domenico Russo, Andrea Bacigalupo, Caterina Musolino
Publikováno v:
The Lancet Haematology. 7:e861-e873
Background: The phase 3 GIMEMA-MMY-3006 trial, which compared bortezomib, thalidomide, and dexamethasone (VTD) combination therapy with thalidomide and dexamethasone (TD) as induction therapy before and consolidation therapy after double autologous h
Autor:
Alessandra Tucci, R. Sartori, Caterina Mammi, Luigi Marcheselli, Salvatrice Mancuso, Alberto Fabbri, Vittorio Ruggero Zilioli, Stefano Luminari, Benedetta Puccini, Maria Christina Cox, Federica Cavallo, Agnese Re, Sergio Storti, G. Gini, Annalisa Arcari, Chiara Bottelli, Chiara Pagani, Giulio Rossi, Michele Spina, Francesco Merli, Monica Balzarotti
Publikováno v:
Hematological Oncology. 39
Autor:
Massimo Midiri, Michele Rizzo, Maurizio Mangione, Alessia Pepe, Esther Oliva, Sara Galimberti, Vincenzo Positano, Stefania Renne, Gennaro Restaino, Antonella Meloni, Sergio Storti, Claudia Baratè, Francesco Arcioni
We prospectively evaluated changes in cardiac and hepatic iron overload (IO) and in morpho-functional cardiac parameters and myocardial fibrosis by magnetic resonance imaging (MRI) in patients with low-risk and intermediate-1-risk myelodysplastic syn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87d2678da30c6d40c78f40854457ed32
http://hdl.handle.net/11577/3414709
http://hdl.handle.net/11577/3414709
Publikováno v:
Oncology Reviews, Vol 6, Iss 1 (2012)
Hematopoiesis, the process by which the hematopoietic stem cells and progenitors differentiate into blood cells of various lineages, involves complex interactions of transcription factors that modulate the expression of downstream genes and mediate p
Externí odkaz:
https://doaj.org/article/76322914300f45aa92cce8987f9a9913
Autor:
Rita Rizzi, Francesco Pisani, Mario Boccadoro, Ombretta Annibali, Nicola Di Renzo, Annalisa Bernardini, Stefano Rocco, Magda Marcatti, Antonio Palumbo, Agostina Siniscalchi, Massimo Offidani, Roberto Vallone, Paola Ferrando, Stefano Spada, Salvatore Palmieri, Riccardo Centurioni, Emanuele Angelucci, Alessandra Larocca, Sergio Storti, Valerio De Stefano, Anna Baraldi, Sara Grammatico, Pellegrino Musto, Vittorio Meneghini, Andrea Evangelista, Enrico Aitini, Alessandro Andriani, Sara Bringhen, Angelo D. Palmas
Publikováno v:
Critical Reviews in Oncology/Hematology. 130:27-35
Early toxic death (≤60 days of diagnosis) in elderly multiple myeloma (MM) patients is attributable to active disease, age and co-morbidities. Rate of early toxic deaths is 10% with conventional chemotherapy mainly due to infection and renal failur
Autor:
Guido Gini, Monica Tani, Renato Bassan, Alessandra Tucci, Filippo Ballerini, Michela Sampaolo, Francesco Merli, Francesca Re, Attilio Olivieri, Mauro Petrini, Ombretta Annibali, Anna Marina Liberati, Carlo Visco, Annalisa Arcari, Sergio Storti, Alberto Fabbri, Gerardo Musuraca, Vittorio Ruggero Zilioli, M. Christina Cox, Stefano Luminari
Publikováno v:
Blood. 138:305-305
INTRODUCTION Treatment of Diffuse Large B cell lymphoma (DLBCL) in the elderly population is challenging as many patients (pts) are not eligible to receive standard curative therapy, due to comorbid conditions and to a higher susceptibility to the si